Table 2.
Demographic, clinical and biochemical characteristics of studied patients (n = 141) with CS divided into three groups depending on the disease activity
| Active disease (n=69) | Remission (n=72) | ||
|---|---|---|---|
| Eucortisolism (n=48) | Hypocortisolism (n=24) | ||
| Etiology: Pituitary/Adrenal | 9/30 | 35/13 | 16/8 |
| Gender (females) | 63 (91.2%) | 39 (79.6%) | 22 (91%) |
| Age (years – mean ± SD) | 47.4 ± 13 | 45.6 ± 11.59 | 49 ± 11 |
| Time since diagnosis (years) | 3.18 ± 4.52 | 9.69 ± 8.05 | 11.33 ± 12 |
| UFC (nmol/24h) | 417.7 (76 – 2000) | 132 (25 – 210) | 45 (19 – 207) |
| Hypertension | 57 (83%) | 30 (63%) | 4 (17%) |
| Diabetes | 26 (38%) | 20 (42%) | 3 (13%) |
| Osteoporosis | 18 (26%) * | 6 (12.5%) ** | 11 (45%) *** |
| Dyslipidemia | 47 (68%) | 24 (50%) | 10 (42%) |
| Global score | 44.9± 17.9 | 47.5±22.9 | |
| Physical score | 43.6 ± 23.1 | 44.8±25.3 | |
| Psychological score | 45.3± 19.1 | 48.3±23.8 | |
Legend: Missing data for:
*
27 pts;
**
13 pts;
***
4 pts.